Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Acta Medica Colombiana
Print version ISSN 0120-2448
Abstract
GARZON-HERNANDEZ, JENNY PAOLA et al. Neurological disease in the time of COVID-19. A case series. Acta Med Colomb [online]. 2022, vol.47, n.4, pp.12-18. Epub May 25, 2023. ISSN 0120-2448. https://doi.org/10.36104/amc.2022.2233.
Introduction:
we present a series of patients with neurological problems and SARS-CoV-2 infection, and review the respective evidence.
Patients and methods:
a retrospective descriptive study of consecutive RT-PCR SARS-CoV-2-positive patients in a neurology department from August 1 to December 31, 2020.
Results:
we recorded 30 patients: 16 men (53%), with a mean age of 65±17.3. In 53%, the neu rological problem preceded the respiratory symptoms and SARS-CoV-2 infection diagnosis. At the syndromic level, the following were found: CVAs 43% (13), seizures 10% (3), posterior reversible encephalopathy 10% (3), encephalopathy 7% (2), brief psychotic disorder 7% (2), myelopathy 3% (1), Guillain-Barré syndrome 3% (1), headache 3% (1), vasculitis 3% (1), intracerebral hemorrhage 3% (1), myasthenic crisis 3% (1) and recurrent optic neuritis 3% (1).
Conclusions:
SARS-CoV-2 induced neurological problems produce a wide variety of symptoms and may be the first manifestation, even without the development of respiratory symptoms from this infection. (Acta Med Colomb 2022; 47. DOI:https://doi.org/10.36104/amc.2022.2233).
Keywords : SARS-CoV-2; COVID-19; neurology; neurological complications; CVA.